Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering.

We have previously shown that transforming growth factor-beta1 (TGF-beta1) stimulates transdifferentiation of fibroblasts into smooth muscle alpha-actin (alpha-SMA) positive myofibroblasts. However, TGF-beta, as such, is unsuitable for effective population of a heart valve matrix, because it dose-dependently inhibits growth of fibroblasts. The aim of this study was to investigate combinations of other growth factors with TGF-beta to stimulate the proliferation of suitably differentiated cells and to enhance their invasion into aortic valve matrices. Human dermal mesenchymal cells (hDMC1.1) were treated with combinations of growth factors to stimulate these cells to trans-differentiate into myofibroblasts, to proliferate, and to invade. Growth factors were chosen after expression of their respective receptors was confirmed in hDMC1.1 using reverse transcriptase polymerase chain reaction. We combined TGF-beta with several growth factors such as insulin-like growth factor (IGF-1, IGF-2), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and platelet-derived growth factor (PDGF-AA, PDGF-BB, and PDGFAB). Nuclear Ki67 staining, MTT assay, and cell counting revealed that only EGF and bFGF were capable of overcoming TGF-beta-induced growth inhibition. However, bFGF but not EGF inhibited TGF-beta-induced alpha-SMA expression, as evidenced by immuno-cytochemistry and Western blotting. A growth factor cocktail (TGF-beta, EGF, bFGF) has been established that maintains TGF-beta-induced trans-differentiation but overcomes TGF-beta-induced growth inhibition while stimulating fibroblast proliferation and invasion.

[1]  M. Mareel,et al.  Molecular mechanisms of cancer invasion , 1997 .

[2]  N. Maihle,et al.  A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor. , 1996, Nucleic acids research.

[3]  P. Cohen,et al.  EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor , 1994, Current Biology.

[4]  M. Yacoub,et al.  Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. , 2000, The Journal of heart valve disease.

[5]  J. Murphy-Ullrich.  The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? , 2001, The Journal of clinical investigation.

[6]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[7]  P. Cohen,et al.  Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. , 1992, The Biochemical journal.

[8]  W G Henderson,et al.  Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. , 2000, Journal of the American College of Cardiology.

[9]  M. Mareel,et al.  The N-cadherin/catenin complex in colon fibroblasts and myofibroblasts. , 1999, Cell adhesion and communication.

[10]  R. Hammer,et al.  Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. , 1997, The Journal of clinical investigation.

[11]  P. Calabresi,et al.  Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS , 1998, Neurology.

[12]  J. Blenis,et al.  Nuclear localization and regulation of erk- and rsk-encoded protein kinases , 1992, Molecular and cellular biology.

[13]  S. Masur,et al.  Fibroblast growth factor reversal of the corneal myofibroblast phenotype. , 2001, Investigative ophthalmology & visual science.

[14]  W. Border,et al.  Transforming growth factor-beta in glomerular injury. , 1994, Experimental nephrology.

[15]  M. Mareel,et al.  Transforming growth factor-beta-induced transition of fibroblasts: a model for myofibroblast procurement in tissue valve engineering. , 2004, The Journal of heart valve disease.

[16]  Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-β or wounding , 2004, Journal of Cell Science.

[17]  H. Yeger,et al.  Acellular matrix: a biomaterials approach for coronary artery bypass and heart valve replacement. , 1995, The Annals of thoracic surgery.

[18]  R. Breathnach,et al.  Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA. , 1993, Molecular and cellular biology.

[19]  C K Breuer,et al.  Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. , 1996, Circulation.

[20]  E. Bruyneel,et al.  Tenascin‐C and SF/HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and Rac , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  F J Schoen,et al.  Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. , 1999, Journal of biomedical materials research.

[22]  S. Masur,et al.  Immunodetection of connexins and cadherins in corneal fibroblasts and myofibroblasts. , 1996, Investigative ophthalmology & visual science.

[23]  Robert W Emery,et al.  The initial experience with the ATS Medical mechanical cardiac valve prosthesis. , 2003, The Annals of thoracic surgery.

[24]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[25]  R. Hobson,et al.  Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production. , 1999, Journal of vascular surgery.

[26]  M. Nicolet,et al.  N-cadherin expression in developing, adult and denervated chicken neuromuscular system: accumulations at both the neuromuscular junction and the node of Ranvier. , 1994, Development.

[27]  G. Gabbiani,et al.  Pathological situations characterized by altered actin isoform expression , 2004, The Journal of pathology.